MUMBAI/NEW DELHI -- At least six Indian pharmaceutical companies have joined the global race to develop a novel coronavirus vaccine, giving a sector better known for making generic copies of drugs a platform to show its innovative capability.
The World Health Organization has listed three Indian companies -- Zydus Cadila, Serum Institute of India and Bharat Biotech -- that are working on a vaccine. In addition, Hyderabad-based companies Biological E and Indian Immunologicals as well as Bangalore-based Mynvax are also involved in development.
